Click it and Unblock the Notifications
Latest Updates
-
Vijay Deverakonda, Rashmika Mandanna’s Pradhanam-Mehendi Looks Redefine Celebrity Wedding Fashion This Year -
Lucky Colours For March 2026 According To Zodiac Signs And The Shades You Should Wear -
Randeep Hooda Becomes Father On His Dad’s Birthday, Shares First Baby Photos In Heartwarming Instagram Post -
World Kidney Day 2026: History, Significance And Theme Behind This Global Health Awareness Day -
Who Is Charulatha Remesh? Sanju Samson’s ‘Dear Pondatti’ Post After India’s T20 World Cup Victory Wins Hearts -
Sheetala Saptami 2026: Significance, Vrat Katha And Why Families Eat Cold Food And Avoid Cooking This Day -
Suryakumar Yadav Takes T20 World Cup Trophy To 526 Year Old Adalaj Stepwell -
Horoscope for Today March 10, 2026 - Calm Energy, Steady Progress -
Women Car Rally Held In Gurugram On International Women’s Day, Boldsky Collaborates As Media Partner -
The Protein Gap In Women’s Diets: Gynaecologist Explains Why This Nutrient Matters From Puberty To Menopause
Each Dose Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Getting Regular Market Approval
The price of Covishield and Covaxin, the COVID-19 vaccines which are expected to soon get regular market approval from India's drug regulator, is likely to be capped at Rs 275 per dose plus an additional service charge of Rs 150, official sources said. According to them, the National Pharmaceutical Pricing Authority (NPPA) has been directed to start working towards capping the price to make the vaccines affordable.
As of now, Covaxin is priced at Rs 1,200 per dose while Covishield costs Rs 780 in private facilities. The prices include Rs 150 service charge. Both the vaccines are only authorised for emergency use in the coAn Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation on January 19 recommended granting regular market approval to COVID vaccines Covishield and Covaxin for use in the adult population subject to certain conditions.
"The NPPA has been asked to work towards capping the price of the vaccines. The price is likely to be capped at Rs 275 per dose along with an additional service charge of Rs 150," an official source said.
Prakash Kumar Singh, the director (government and regulatory affairs) at Serum Institute of India, had submitted an application to the Drugs Controller General of India on October 25 seeking regular market approval for its Covishiled vaccine.
A couple of weeks ago, V Krishna Mohan, the whole-time director at Bharat Biotech, submitted complete information on the chemistry, manufacturing and controls, along with the pre-clinical and clinical data while seeking regular market authorisation for Covaxin.
Covaxin and Covishield were granted Emergency Use Authorisation (EUA) on January 3 last year.
COVID vaccine - Photo by DW News / Getty Images.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google